Anticancer properties of a new non-oxido vanadium(IV) complex with a catechol-modified 3,3′-diindolylmethane ligand

Add time:08/28/2019    Source:sciencedirect.com

In order to identify new active drug candidates against cancer diseases we investigated the tumor cell growth inhibition, formation of reactive oxygen species, mitochondrial membrane damage, cell cycle arrest and DNA binding activity of a new bis(triethylammonium) tris[1,1-bis(indol-3-yl)-1-(3,4-catecholate)methane]vanadate(IV) complex. It exhibited significant antiproliferative activity against various cancer cell lines, showed a stronger DNA binding than cisplatin and led to mitochondrial damage, a formation of reactive oxygen species, and a cell cycle arrest in the G2/M phase of cancer cells.

We also recommend Trading Suppliers and Manufacturers of VANADIUM IODIDE (cas 15513-84-5). Pls Click Website Link as below: cas 15513-84-5 suppliers

Prev:A high-energy and low-cost polysulfide/iodide redox flow battery
Next:Recovery of V(V) from complex vanadium solution using capacitive deionization (CDI) with resin/carbon composite electrode)